New eczema drug shows promise in Mid-Stage trial

This study tested an experimental drug called LW402 in 144 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug reduces eczema severity, measured by a 50% improvement in skin symptoms after 12 weeks. Participants were randomly assigned to receive either LW402 or a placebo, and neither they nor their doctors knew which treatment they received. The results will help determine if LW402 is safe and effective enough to move into larger trials.